ELDN Insider Trading

Insider Ownership Percentage: 11.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Eledon Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Eledon Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Eledon Pharmaceuticals Share Price & Price History

Current Price: $5.30
Price Change: Price Increase of +0.65 (13.98%)
As of 11/1/2024 01:00 AM ET

This chart shows the closing price history over time for ELDN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Eledon Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2021David-Alexandre C. GrosCEOBuy2,000$4.48$8,960.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Eledon Pharmaceuticals (NASDAQ:ELDN)

56.77% of Eledon Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ELDN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Eledon Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/30/2024Clarity Capital Partners LLC11,500$29K0.0%N/A0.029%Search for SEC Filing on Google Icon
8/20/2024Nantahala Capital Management LLC600,000$1.58M0.1%N/A2.418%Search for SEC Filing on Google Icon
8/15/2024Armistice Capital LLC2,336,000$6.17M0.1%+1.7%9.414%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC136,773$0.36M0.0%+57.1%0.551%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP30,233$80K0.0%N/A0.122%Search for SEC Filing on Google Icon
8/8/2024Marco Investment Management LLC30,344$80K0.0%+22.3%0.122%Search for SEC Filing on Google Icon
5/14/2024CM Management LLC160,000$0.33M0.3%+14.3%0.645%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.969,121$2M0.0%+39.4%3.906%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC2,189,000$3.94M0.1%+20.0%9.045%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC1,824,000$2.50M0.0%-1.0%7.538%Search for SEC Filing on Google Icon
10/19/2023Jmac Enterprises LLC58,041$80K0.0%-27.5%0.246%Search for SEC Filing on Google Icon
8/15/2023BVF Inc. IL4,326,710$5.93M0.2%+86.0%18.372%Search for SEC Filing on Google Icon
8/11/2023SVB Financial Group18,025$25K0.0%-33.1%0.080%Search for SEC Filing on Google Icon
7/20/2023Jmac Enterprises LLC80,041$0.11M0.0%+46.8%0.356%Search for SEC Filing on Google Icon
2/9/2023CM Management LLC234,800$0.54M0.6%-4.2%1.706%Search for SEC Filing on Google Icon
11/14/2022Cormorant Asset Management LP1,223,500$3.38M0.2%-6.3%8.894%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.375,000$1.04M0.0%-12.5%2.726%Search for SEC Filing on Google Icon
11/14/2022Boothbay Fund Management LLC22,050$61K0.0%-36.3%0.160%Search for SEC Filing on Google Icon
11/4/2022CM Management LLC245,000$0.68M0.8%+8.9%1.781%Search for SEC Filing on Google Icon
8/16/2022Woodline Partners LP516,675$1.26M0.0%-23.2%3.755%Search for SEC Filing on Google Icon
5/9/2022CM Management LLC225,000$0.89M0.7%+95.7%1.636%Search for SEC Filing on Google Icon
4/25/2022Bailard Inc.27,600$0.11M0.0%N/A0.193%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.431,435$1.90M0.0%+105.9%3.016%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc77,100$0.34M0.0%+966.7%0.539%Search for SEC Filing on Google Icon
2/7/2022Ameritas Advisory Services LLC24,219$0.11M0.0%N/A0.169%Search for SEC Filing on Google Icon
2/2/2022CM Management LLC115,000$0.51M0.4%+53.3%0.804%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP115,900$0.72M0.0%+48.0%0.810%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP115,324$0.71M0.0%+100.5%0.806%Search for SEC Filing on Google Icon
11/16/2021BVF Inc. IL1,363,435$8.43M0.3%+22.5%9.530%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.209,490$1.30M0.0%+11.0%1.464%Search for SEC Filing on Google Icon
11/15/2021Eversept Partners LP114,008$0.71M0.1%N/A0.797%Search for SEC Filing on Google Icon
11/15/2021Ensign Peak Advisors Inc7,228$45K0.0%-80.0%0.051%Search for SEC Filing on Google Icon
11/10/2021Mercer Global Advisors Inc. ADV16,726$0.10M0.0%N/A0.117%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC350,000$2.77M0.2%+40.0%2.446%Search for SEC Filing on Google Icon
8/17/2021Woodline Partners LP857,445$6.78M0.1%-3.8%5.993%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC40,052$0.32M0.0%+39.6%0.280%Search for SEC Filing on Google Icon
8/16/2021Point72 Asset Management L.P.188,690$1.49M0.0%+51.0%1.319%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley851,004$6.73M0.0%+7,235.6%5.948%Search for SEC Filing on Google Icon
8/16/2021State Street Corp32,935$0.26M0.0%N/A0.230%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC21,107$0.17M0.0%-22.0%0.148%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp32,116$0.25M0.0%+106.8%0.224%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC124,614$0.99M0.0%+25.7%0.871%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.209,750$1.66M0.0%-8.8%1.466%Search for SEC Filing on Google Icon
5/19/2021Logos Global Management LP224,071$2.40M0.2%N/A1.566%Search for SEC Filing on Google Icon
5/18/2021BVF Inc. IL1,113,435$11.91M0.4%N/A7.782%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC14,588$0.16M0.0%N/A0.102%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.125,000$1.34M0.0%N/A0.874%Search for SEC Filing on Google Icon
5/18/2021Cormorant Asset Management LP1,415,500$15.15M0.3%N/A9.894%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC25,062$0.27M0.0%N/A0.175%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP891,055$9.53M0.2%N/A6.228%Search for SEC Filing on Google Icon
5/17/2021EcoR1 Capital LLC1,115,721$11.94M0.5%N/A7.798%Search for SEC Filing on Google Icon
5/17/2021Janus Henderson Group PLC213,899$2.25M0.0%N/A1.495%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC250,000$2.68M0.1%N/A1.747%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC27,051$0.29M0.0%N/A0.189%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp15,528$0.17M0.0%N/A0.109%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC99,123$1.06M0.0%N/A0.693%Search for SEC Filing on Google Icon
5/12/2021CM Management LLC75,000$0.80M0.6%N/A0.524%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.12,282$0.13M0.0%N/A0.086%Search for SEC Filing on Google Icon
4/21/2021Ingalls & Snyder LLC51,149$0.55M0.0%N/A0.358%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Eledon Pharmaceuticals logo
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Read More on Eledon Pharmaceuticals

Today's Range

Now: $5.30
Low: $4.66
High: $5.54

50 Day Range

MA: $2.87
Low: $2.44
High: $5.30

52 Week Range

Now: $5.30
Low: $1.07
High: $5.54

Volume

1,138,378 shs

Average Volume

774,330 shs

Market Capitalization

$210.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76

Who are the major institutional investors of Eledon Pharmaceuticals?

Eledon Pharmaceuticals' top institutional shareholders include:
  1. Clarity Capital Partners LLC — 0.03%
Learn More about top institutional investors of Eledon Pharmaceuticals stock.

Which major investors are buying Eledon Pharmaceuticals stock?

During the last quarter, ELDN stock was acquired by institutional investors including:
  1. Clarity Capital Partners LLC